Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
110-mg dose of E5501 2G tablet----1件: 63
210-mg dose of E5501 cyclodextrin oral solution----1件: 63
310-mg dose of E5501 lipid-based oral----1件: 63
410-mg dose of E5501-P21% powder----1件: 63
5Acetominofene----2件: 11, 63
6Acetominophen----1件: 63
7Acetylcysteine1件: Acetylcysteine1件: D00221 --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
8AKR-501, YM-477----1件: 63
9ALEMTUZUMAB1件: Alemtuzumab1件: D02802 1件: CD52 💬-17件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284
10Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 		2件: CD52,
MS4A1 💬		-1件: 63
11All-Trans Retinoid Acid(ATRA)1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 63
12AMG 531----1件: 63
13AMG531----2件: 60, 63
14Aminophylline1件: Aminophylline1件: D00227 18件: ADORA1,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 63
15Amoxicillin1件: Amoxicillin2件: D00229 ,
D07452 		--7件: 6, 46, 63, 96, 97, 222, 299
16Amoxicillin hydrate1件: Amoxicillin2件: D00229 ,
D07452 		--1件: 63
17Amoxycillin1件: Amoxicillin2件: D00229 ,
D07452 		--1件: 63
18Anti-CD40L1件: Toralizumab1件: D06193 1件: CD40LG 💬14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬1件: 63
19Anti-CD40LdAb----1件: 63
20Anti-D----1件: 63
21ARGX-113----5件: 11, 14, 35, 53, 63
22Atorvastatin1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
23Atorvastatin 10mg1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
24Atorvastatin 20mg1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
25Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet2件: Acetylcysteine,
Atorvastatin		2件: D00221 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63
26ATRA1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬2件: 63, 94
27Avatrombopag1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬2件: 60, 63
28Avatrombopag (proposed)1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
29AVATROMBOPAG MALEATE1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
30Avatrombopag tablets1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
31Azathioprine1件: Azathioprine1件: D00238 --21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162
32BELIMUMAB1件: Belimumab1件: D03068 1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300
33Blinded (Avatrombopoag tablets)----1件: 63
34Blisibimod1件: Blisibimod1件: D10311 --5件: 43, 44, 49, 63, 66
35BMS-986004----1件: 63
36BMS-986004 1500 mg IV----1件: 63
37BMS-986004 225 mg IV----1件: 63
38BMS-986004 675 mg IV----1件: 63
39BMS-986004 75 mg IV----1件: 63
40BORTEZOMIB1件: Bortezomib1件: D03150 1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331
41BT595----2件: 63, 65
42Caffeic acid tablets----1件: 63
43CD----8件: 6, 13, 46, 51, 63, 96, 97, 265
44Clarithromycin1件: Clarithromycin1件: D00276 --8件: 6, 63, 84, 96, 97, 222, 228, 299
45Combination of Rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63
46Combination of Rituximab with subcutaneous belimumab2件: Belimumab,
Rituximab		2件: D02994 ,
D03068 		2件: MS4A1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63
47Conventional----1件: 63
48Corticosteroids----12件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300
49Corticosteroids (Aprednislon)----1件: 63
50CsA----8件: 19, 49, 50, 53, 60, 63, 222, 228
51Cyclosporin1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326
52Cyclosporin A1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164
53Cyclosporine1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬37件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302
54Danazol1件: Danazol1件: D00289 3件: AR,
ESR1,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 60, 63, 64, 65, 285
55Daratumumab1件: Daratumumab1件: D10777 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬5件: 13, 28, 48, 49, 63
56Daratumumab Injection1件: Daratumumab1件: D10777 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 49, 63
57Darzalex1件: Daratumumab1件: D10777 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 49, 63
58Decitabine1件: Decitabine1件: D03665 3件: DNMT1,
DNMT3A,
DNMT3B 💬		3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬2件: 60, 63
59Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
60Dexamethasone (1 cycle)1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
61Dexamethasone (4 cycles)1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
62Dexamethasone Abcur1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
63Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab		2件: D00292 ,
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63
64DIACEREIN1件: Diacerein1件: D07270 --3件: 36, 46, 63
65Diammonium glycyrrhizinate enteric-coated capsule----1件: 63
66Difenidramina----2件: 11, 63
67DIFENIDRAMINA CLORIDRATO----3件: 11, 19, 63
68Doptelet1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
69Doptelet 20 mg film-coated tablets1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
70Doxil----1件: 63
71Dyphenhydramine hydrochloride----1件: 63
72E5501----1件: 63
73E5501 40 mg 2 x 20-mg tablets, orally, fasted----1件: 63
74E5501 40 mg 2 x 20-mg tablets, orally, with food----1件: 63
75E5501 40mg 2 x 20-mg tablets, orally, fasted----1件: 63
76Efgartigimod----4件: 11, 35, 53, 63
77EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: D11876 1件: FCGRT 💬-6件: 11, 14, 35, 53, 63, 162
78Efgartigimod alpha----1件: 63
79Efgartigimod PH20 SC----5件: 11, 14, 35, 63, 162
80ELTROMBOPAG1件: Eltrombopag---5件: 60, 63, 65, 284, 285
81Eltrombopag (Revolade)1件: Eltrombopag---1件: 63
82Eltrombopag (Revolade®)1件: Eltrombopag---1件: 63
83Eltrombopag combining rituximab2件: Eltrombopag,
Rituximab		1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63
84ELTROMBOPAG OLAMINE1件: Eltrombopag---2件: 60, 63
85Eltrombopag olamine (SB-497115-GR)1件: Eltrombopag---1件: 63
86Eltrombopag olamine, Revolade, Promacta1件: Eltrombopag---1件: 63
87Eltrombopag oral tablets1件: Eltrombopag---1件: 63
88Eltrombopag plus diacerein2件: Diacerein,
Eltrombopag		1件: D07270 --1件: 63
89Gammaplex----2件: 63, 65
90Gammaplex, intravenous immunoglobulin----1件: 63
91Global DNA methylation will be quantified in the DNA samples by colorimetry----1件: 63
92Glycyrrhetinic Acid----1件: 63
93GMA161----1件: 63
94GNR-069----1件: 63
95Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318
96HBM9161 Dose A----1件: 63
97HBM9161 Dose B----1件: 63
98Herombopag----2件: 60, 63
99Hetrombopag1件: Hetrombopag---2件: 60, 63
100Hetrombopag Olamine1件: Hetrombopag---2件: 60, 63
101High dose Dexamethasone pulses1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
102HMPL-523----2件: 46, 63
103Huaiqihuang Granule----2件: 63, 222
104Human Immunoglobulin----2件: 63, 65
105HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65
106Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65
107HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65
108HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE1件: Human immunoglobulin G---2件: 63, 65
109HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE1件: Human immunoglobulin G---1件: 63
110Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65
111HUMAX-CD38----2件: 28, 63
112Hydroxychloroquine1件: Hydroxychloroquine1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
113I10E----3件: 14, 63, 65
114Ianalumab1件: Ianalumab1件: D12151 1件: TNFRSF13C 💬5件: Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬7件: 35, 46, 49, 53, 61, 63, 95
115Ig VENA----2件: 50, 63
116Ig VENA 100 ml vial----1件: 63
117Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set----2件: 63, 65
118IgG Next Generation----2件: 63, 65
119IGIV3I Grifols 10%----1件: 63
120IgNextGen 10%----1件: 63
121Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution----1件: 63
122Immunglobulin----1件: 63
123Immunoglobulin----3件: 13, 14, 63
124IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65
125Inactivated Trivalent Influenza vaccine----1件: 63
126INTERLEUKIN 2----9件: 46, 49, 51, 56, 63, 95, 96, 97, 271
127Intravenous immunoglobulin (IVIG), 10% solution for infusion----1件: 63
128IVIG-L----1件: 63
129L01FC01----1件: 63
130Lansoprazole1件: Lansoprazole1件: D00355 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬7件: 63, 71, 85, 98, 166, 222, 299
131Lansoprazole, clarithromycin, amoxycillin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		4件: D00229 ,
D00276 ,
D00355 ,
D07452 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 63
132LIV-GAMMA SN Inj.----1件: 63
133LIV-GAMMA SN Inj.10%----1件: 63
134MabThera1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
135Medical Standard of Care for ITP----1件: 63
136Methylprednisolone1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
137METILPREDNISOLONE----6件: 11, 13, 53, 56, 63, 300
138METRONIDAZOLE1件: Metronidazole1件: D00409 --7件: 46, 51, 63, 94, 96, 97, 291
139Mezagitamab1件: Mezagitamab1件: D11945 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬2件: 63, 66
140Mg----5件: 6, 13, 51, 63, 111
141Montelukast1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬8件: 6, 13, 46, 61, 63, 85, 98, 228
142Nanogam----1件: 63
143NewGam----3件: 14, 63, 65
144NPLATE1件: Romiplostim1件: D08990 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
145NPLATE 500 microgramos polvo para solución inyectable1件: Romiplostim1件: D08990 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
146Null----16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271
147Octagam 10%----3件: 50, 63, 65
148Octagam® 10%----1件: 63
149Open Label (Avatrombopag tablets)1件: Avatrombopag1件: D10306 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63
150Orelabrutinib1件: Orelabrutinib1件: D12160 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬4件: 13, 49, 61, 63
151Orelabrutinib( higher dose)1件: Orelabrutinib1件: D12160 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63
152Orelabrutinib( lower dose)1件: Orelabrutinib1件: D12160 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63
153Palmitate1件: Palmitic Acid1件: D05341 --1件: 63
154PARACETAMOLO----9件: 2, 11, 14, 19, 28, 53, 61, 63, 300
155PF-06755347 intravenous healthy participant----1件: 63
156PF-06755347 subcutaneous healthy participant----1件: 63
157PF-06755347 subcutaneous ITP----1件: 63
158PF-06835375----3件: 46, 49, 63
159PG2----1件: 63
160Placebo----28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
161Povetacicept----3件: 61, 63, 222
162PREDNISOLONE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
163Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
164Privigen®1件: Human immunoglobulin G---3件: 14, 63, 65
165Promacta1件: Eltrombopag---2件: 63, 65
166Proteína recombinante estimulante de la megacariopoyesis----1件: 63
167PRTX-100 (Staphylococcal protein A)1件: Bevifimod---1件: 63
168QL0911----1件: 63
169R788----2件: 46, 63
170Recombinant Human Thrombopoietin2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63
171Recombinant human thrombopoietin (rh-TPO)2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63
172Recombinant Human Thrombopoietin (rhTPO)2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63
173Relovade----1件: 63
174REVOLADE1件: Eltrombopag---2件: 60, 63
175Revolade 25 mg film-coated tablets1件: Eltrombopag---1件: 63
176Revolade 50 mg film-coated tablets1件: Eltrombopag---1件: 63
177REVOLADE, PROMACTA1件: Eltrombopag---1件: 63
178RhTPO1件: Recombinant Human Thrombopoietin---2件: 60, 63
179RhTPO in combination with Rituximab2件: Recombinant Human Thrombopoietin,
Rituximab		1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63
180RITUXIMAB1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
181Rituximab [MabThera/Rituxan]1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 63
182Romiplostim1件: Romiplostim1件: D08990 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65
183Romiplostim plus dexamethasone2件: Dexamethasone,
Romiplostim		2件: D00292 ,
D08990 		2件: MPL,
NR3C1 💬		3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63
184Romiplostin----1件: 63
185ROZANOLIXIZUMAB1件: Rozanolixizumab1件: D12182 1件: FCGRT 💬-3件: 11, 14, 63
186SB-497115----1件: 63
187SB-497115-GR----1件: 63
188SB-497115-GR 12.5mg----1件: 63
189SB-497115-GR 25mg----1件: 63
190SB-497115-GR 50 mg----1件: 63
191SB497115----2件: 60, 63
192Sirolimus1件: Sirolimus1件: D00753 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬35件: 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331
193SM101----3件: 49, 63, 66
194SM101 20mg/mL----1件: 63
195SM101 5mg/mL----1件: 63
196Standard of Care----8件: 6, 13, 49, 51, 63, 64, 79, 171
197Standard therapy (without eltrombopag): HD-DXM1件: Eltrombopag---1件: 63
198STAPHYLOCOCCAL PROTEIN A1件: Bevifimod---1件: 63
199Steroids----7件: 46, 50, 51, 63, 66, 96, 97
200TAK-079----3件: 11, 49, 63
201Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication)3件: Amoxicillin,
Clarithromycin,
Metronidazole		4件: D00229 ,
D00276 ,
D00409 ,
D07452 		--1件: 63
202Thrombopoietin1件: Thrombopoietin---3件: 47, 60, 63
203TPO----1件: 63
204TPO-RA----1件: 63
205TPO-RAs----1件: 63
206TPO-RAs combining anti-CD 20 monoclonal antibody----1件: 63
207Triple therapy----2件: 50, 63
208TYSABRI1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬3件: 13, 25, 63
209UCB7665----3件: 11, 14, 63
210VAY736----9件: 13, 35, 46, 49, 53, 61, 63, 85, 95
211Vonoprazan1件: Vonoprazan1件: D11784 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 63, 98
212Water1件: Water1件: D00001 --21件: 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299
213Zanubrutinib1件: Zanubrutinib1件: D11422 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬5件: 13, 63, 222, 300, 331